VANGUARD GROUP INC 13D and 13G filings for Arcus Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 4:58 pm Purchase | 2023-12-29 | 13G | Arcus Biosciences, Inc. RCUS | VANGUARD GROUP INC | 4,680,716 6.250% | 307,539 (+7.03%) | Filing |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | Arcus Biosciences, Inc. RCUS | VANGUARD GROUP INC | 4,373,177 6.040% | 4,373,177 (New Position) | Filing |